Cardinal Health (CAH) Stock Looks Fully Priced On Its 403% Run

Cardinal Health (CAH) stock has seen a significant 403% return over the past five years, but its current valuation appears expensive, trading at 34.6x earnings, above the industry average of 25.0x. While recent acquisitions like Strive Medical and AdaptHealth’s diabetes business may drive growth, the stock's premium pricing suggests limited room for further appreciation based on traditional metrics and fair value estimates. Investors are advised to consider whether the company can sustain strong earnings and integration execution to justify its current high P/E multiple.